Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients.
Kuo-Tung TangTsai-Ling LiaoYi-Hsing ChenDer-Yuan ChenKou-Lung LaiPublished in: Biomedicines (2023)
FM patients likely benefited from subcutaneous tocilizumab therapy. A randomized controlled trial is needed to verify its efficacy.